bisoprolol has been researched along with Diabetic Glomerulosclerosis in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wai, B | 1 |
| Kearney, LG | 1 |
| Hare, DL | 1 |
| Ord, M | 1 |
| Burrell, LM | 1 |
| Srivastava, PM | 1 |
1 other study available for bisoprolol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Albuminuria; Biomarkers; Bisoprolol; Carbazole | 2012 |